MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SNDX
  4. News
SNDX
Quote
Short
News
Articles
Message Board

Syndax Pharmaceuticals Inc. (NASDAQ : SNDX ) News

News Releases

SNDX News Releases
SNDX : NASDAQ
SeekingAlpha
Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade)
SNDX : NASDAQ
KlickAnalytics
Buy Recommendation Issued On SNDX By UBS
SNDX : NASDAQ
SeekingAlpha
Syndax Pharmaceuticals: The Duration Expansion Story Is Being Underpriced
SNDX : NASDAQ
GlobeNewswire
Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026
SNDX : NASDAQ
GlobeNewswire
Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology
SNDX : NASDAQ
SeekingAlpha
Syndax Pharmaceuticals, Inc. (SNDX) Shareholder/Analyst Call Prepared Remarks Transcript
SNDX : NASDAQ
SeekingAlpha
Syndax Pharmaceuticals, Inc. (SNDX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
SNDX : NASDAQ
SeekingAlpha
Syndax Pharmaceuticals prices $250M senior convertible notes
SNDX : NASDAQ
GlobeNewswire
Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes
SNDX : NASDAQ
GlobeNewswire
Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.